NRF2 inhibitors: Recent progress, future design and therapeutic potential.

Area of Science:

• Molecular Biology
• Oncology
• Pharmacology

Background:

• Nuclear factor erythroid 2-related factor 2 (NRF2) is a key regulator of oxidative stress response.
• Constitutive NRF2 activation is linked to chemotherapy resistance and poor prognosis in cancer patients.

Purpose of the Study:

• To provide a comprehensive review of NRF2 inhibitors for cancer therapy.
• To analyze the NRF2 signaling pathway, its regulation, and current inhibitor designs.
• To discuss future prospects for developing novel NRF2 inhibitors.

Main Methods:

• Literature review of NRF2 signaling pathway.
• Systematic search and analysis of reported NRF2 inhibitors.
• Discussion of structure-activity relationships and design strategies.

Main Results:

• Detailed overview of NRF2 pathway components and regulation mechanisms.
• Compilation and categorization of various NRF2 inhibitors.
• Identification of challenges and opportunities in NRF2 inhibitor development.

Conclusions:

• NRF2 inhibitors represent a promising strategy to combat drug resistance in cancer.
• Further research into NRF2 inhibitor design is crucial for clinical translation.
• This review serves as a foundation for future development of effective NRF2-targeted therapies.